Same Indication

Ipilimumab vs Metronidazole

Ipilimumab vs Metronidazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Metronidazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Metronidazole — 8 hours.

Chemical Properties

Molecular Formula: Metronidazole — C6H9N3O3.

Molecular Weight: Metronidazole — 171.1540 g/mol.

Type: Ipilimumab — Antibody; Metronidazole — Small molecule.